d-glucuronyl C5-epimerase (GLCE) was shown as a potential tumor suppressor gene which participated in lung and breast carcinogenesis [20, 21] by inhibiting tumor angiogenesis and invasion/metastasis pathways, which was also proved to affect angiogenesis in prostate cancer cells [22]. This evidence concerns the gene GLCE and prostate carcinoma.